CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
47 hedge funds and large institutions have $593M invested in China Biologic Products Holdings, Inc. in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% more capital invested
Capital invested by funds: $407M → $593M (+$186M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.64M
Holders
47
Holding in Top 10
2
Calls
–
Puts
$1.64M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$10M | |
| 3 | +$7.99M | |
| 4 |
Morgan Stanley
New York
|
+$7.68M |
| 5 |
EMR
Errol M. Rudman
|
+$4.9M |
Top Sellers
| 1 | -$2.4M | |
| 2 | -$835K | |
| 3 | -$420K | |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
-$218K |
| 5 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$168K |